CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr | ₹31 Cr | ₹-43 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-99 Cr |
Mar2023 | ₹-85 Cr |
Mar2022 | ₹-100 Cr |
Mar2021 | ₹31 Cr |
Mar2020 | ₹-43 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-99 Cr | Negative | |
Mar2023 | ₹-85 Cr | Negative | |
Mar2022 | ₹-100 Cr | Negative | |
Mar2021 | ₹31 Cr | Positive | |
Mar2020 | ₹-43 Cr | - |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹22,720.2 Cr | 9.9% | 2.4% | 44.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 9.9% |
2.4% |
44.8% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses